Literature DB >> 15226211

Clinical and economic outcomes of percutaneous coronary interventions in the elderly: an analysis of medicare claims data.

Mary Ann Clark1, Ameet Bakhai, Michael J Lacey, Elise M Pelletier, David J Cohen.   

Abstract

BACKGROUND: Outcomes after percutaneous coronary intervention (PCI) have been documented extensively in clinical trials and single-center series, but few data exist on the clinical and economic outcomes after PCI in an unselected population. METHODS AND
RESULTS: We used the Medicare Standard Analytic File to identify all initial PCI procedures performed in 1998 among a random sample of 5% of all Medicare beneficiaries > or =65 years of age. These patients (n=9868) were followed up for 1 year after PCI to identify clinical outcomes, medical resource use, and costs. Between 1 month and 1 year after PCI, 16.9% of patients required > or =1 repeat revascularization procedures. Mean 1-year medical care costs increased 5-fold among patients with repeat revascularization compared with those without (26,186 dollars versus 5344 dollars; P<0.001). After adjustment for baseline differences, the independent cost of repeat revascularization was 19,074 dollars (95% CI, 18,440 to 19,707). Assuming from previous studies that 85% of repeat revascularization procedures over the first year of follow-up are attributable to restenosis, the estimated clinical restenosis rate was 14.4%, and the 1-year economic burden of restenosis to the healthcare system was 2747 dollars per initial PCI procedure.
CONCLUSIONS: Among unselected elderly patients undergoing PCI, repeat revascularization occurs in approximately 14% and increases 1-year healthcare costs by >19,000 dollars per occurrence. These findings have important implications for the cost-effectiveness of new treatments that substantially reduce restenosis.

Entities:  

Mesh:

Year:  2004        PMID: 15226211     DOI: 10.1161/01.CIR.0000135589.85501.DB

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Drug-eluting stents in the elderly.

Authors:  Samip Vasaiwala; Daniel E Forman; Laura Mauri
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-01

2.  Enhanced biocompatibility of CD47-functionalized vascular stents.

Authors:  Joshua B Slee; Ivan S Alferiev; Chandrasekaran Nagaswami; John W Weisel; Robert J Levy; Ilia Fishbein; Stanley J Stachelek
Journal:  Biomaterials       Date:  2016-02-08       Impact factor: 12.479

3.  The association of the number of comorbidities and complications with length of stay, hospital mortality and LOS high outlier, based on administrative data.

Authors:  Kazuaki Kuwabara; Yuichi Imanaka; Shinya Matsuda; Kiyohide Fushimi; Hideki Hashimoto; Koichi B Ishikawa; Hiromasa Horiguchi; Kenshi Hayashida; Kenji Fujimori
Journal:  Environ Health Prev Med       Date:  2008-03-29       Impact factor: 3.674

Review 4.  Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes.

Authors:  A Bakhai; R A Hill; Y Dundar; R Dickson; T Walley
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

Review 5.  The economic consequences of diabetes and cardiovascular disease in the United States.

Authors:  Miguel A Ariza; Varsha G Vimalananda; James L Rosenzweig
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

6.  Predicting target vessel revascularization in older patients undergoing percutaneous coronary intervention in the drug-eluting stent era.

Authors:  Connie N Hess; Sunil V Rao; David Dai; Megan L Neely; Robert N Piana; John C Messenger; Eric D Peterson
Journal:  Am Heart J       Date:  2014-01-04       Impact factor: 4.749

Review 7.  Clinical and economic studies of eptifibatide in coronary stenting.

Authors:  Tilak Pasala; Prasongchai Sattayaprasert; Pradeep K Bhat; Ganesh Athappan; Sanjay Gandhi
Journal:  Ther Clin Risk Manag       Date:  2014-08-02       Impact factor: 2.423

8.  Duration of Heightened Ischemic Stroke Risk After Acute Myocardial Infarction.

Authors:  Alexander E Merkler; Ivan Diaz; Xian Wu; Santosh B Murthy; Gino Gialdini; Babak B Navi; Shadi Yaghi; Jonathan W Weinsaft; Peter M Okin; Monika M Safford; Costantino Iadecola; Hooman Kamel
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

9.  The association between epicardial fat thickness in echocardiography and coronary restenosis in drug eluting stents.

Authors:  Fariborz Nikaeen; Masoud Pourmoghadas; Hasan Shemirani; Seid Ahmad Mirdamadi; Mojtaba Akbari
Journal:  ARYA Atheroscler       Date:  2011
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.